Immunology of Bacille Calmette-Guérin and Related Topics
Open Access
- 1 September 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (Supplement), S59-S63
- https://doi.org/10.1086/314063
Abstract
This supplement is based on a workshop held in Toronto, Ontario, on 11–13 July 1994, at the site of the sponsor, Pasteur-Mérieux-Connaught Canada. The 3-day workshop focused on immunologic responses to BCG, its use in the prevention of tuberculosis and in the treatment and prophylaxis of bladder cancer, and its potential applications for other cancers.Keywords
This publication has 3 references indexed in Scilit:
- MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDYJournal of Urology, 2000
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976